Astellas Pharma Inc. Newsletter
-
Fierce Pharma Asia—AZ-CSPC deal; FDA's American cell shipping ban; China's trial review acceleration plan
20 Jun 2025 16:01 GMT
… ’s CSPC Pharmaceutical $110 million upfront to discover new oral drugs for chronic … ;heightened risks' for pharma: PwC
As more pharma licensing deals feature Chinese … Simcere's phase 1 drug
8. Astellas offers lab space to startups …
-
10.0% CAGR Fuels Top 10 Cancer Drugs Market to $198.8 Billion by 2032
19 Jun 2025 21:41 GMT
… of different types of drugs such as hormone therapy, … as -
AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Bristol- … identify potential top 10 cancer drugs market opportunities in genetics.
… cost associated with new drug development and side effects …
-
AI in Drug Discovery and Development Market Size, Trends, Growth Forecast 2025–2033 | DataM Intelligence
19 Jun 2025 12:45 GMT
… disorders.
Japan
March 2025 – Astellas Pharma collaborated with Tokyo-based AI … prediction and drug design pipelines.
September 2024 – Takeda Pharmaceuticals initiated an … :
AI is revolutionizing the drug discovery and development landscape, …
-
Nikon Instruments and Astellas collaborate to offer SakuLab─Cambridge resident companies access to advanced imaging capabilities
19 Jun 2025 11:38 GMT
… a wholly owned subsidiary of Astellas Pharma Inc, have entered a … have a strategic collaboration with Astellas," said Fumiki Yanagawa … research and development of drug therapies, and to help … head of Innovation Lab at Astellas. "By providing cutting …
-
10 Year Non-small Cell Lung Cancer Seven-Market Drug Forecast and Market Analysis 2022-2032: Focus on US, France, Germany, Italy, Spain, UK, and Japan - ResearchAndMarkets.com
18 Jun 2025 18:49 GMT
… forecasts leverage data on pharmaceutical sales and drug availability from the analyst … forecasts leverage data on pharmaceutical sales and drug availability from the analyst … Ingelheim
Janssen
Eli Lylly
Genmab
Astellas
Mirati Therapeutics
Amgen
WuXi Advanced …
-
Multispecific Antibodies Market, Drug Sales, Dosage, Price & Clinical Trials Insight 2030: 18 Multispecific Antibodies Approved Globally with Strong Market Performance - ResearchAndMarkets.com
17 Jun 2025 18:07 GMT
… offering.
Global Multispecific Antibodies Market, Drug Sales, Dosage, Price & … This expanding portfolio boasts trailblazing drugs like Blincyto, the first …
Amgen
Antibody Therapeutics
APITBIO
Astellas Pharma
AstraZeneca
Aptevo Therapeutics
BioAtla
…
-
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
17 Jun 2025 12:11 GMT
… in certain settings. Other drugmakers say they are inching … payloads for these drugs.
The pharmaceutical industry is working … .
Padcev from Pfizer and Astellas Pharma is approved with Merck… eligible patients for the drug.
Combinations are key
Chemotherapy …
-
Global Metastatic Lung Adenocarcinoma Treatment Market To Reach $6.64 Billion By 2029 With A Growth Rate Of 9.9%
20 Jun 2025 11:00 GMT
… factors, increased approval of novel drug therapies, a burgeoning healthcare … Inc., Boehringer Ingelheim International GmbH, Astellas Pharma Inc., Exelixis, BeiGene Ltd., Novocure … Research Company:
Lung Cancer Drugs Global Market Report 2025
https …
-
Leading Driver In The Oral Hypoglycemic Agents Market 2025: Rising Prevalence Of Type 2 Diabetes Driving Growth
20 Jun 2025 10:55 GMT
… fixed-dose combinations, advancements in drug formulation technology, a concentrated effort … toward reducing drug side effects, and the integration … ., Novo Nordisk A/S, Astellas Pharma Inc., Laboratoires Servier, Huadong Medicine …
-
Pharma Pulse 6/16/25: What Actually Moves the Needle on Inclusive Research; The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence
16 Jun 2025 18:04 GMT
… Clinical and Economic Evidence
Pharmacists are increasingly playing a … potential of its antipsychotic drug Cobenfy, pointing to positive … drive long-term growth.
Astellas Offers Lab Space to … 'Go Global'
Astellas Pharma is offering lab space, expert …
About
© 1995-2025